Well Lead Medical Co., Ltd. (SHA:603309)

Market Cap	3.09B -26.6%
Revenue (ttm)	1.66B +1.1%
Net Income	33.00M -86.5%
EPS	0.11 -86.3%
Shares Out	291.87M
PE Ratio	93.32
Forward PE	9.81
Dividend	0.60 (5.66%)
Ex-Dividend Date	May 28, 2026

Volume	1,396,000
Open	10.63
Previous Close	10.60
Day's Range	10.55 - 10.74
52-Week Range	10.30 - 16.42
Beta	-0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation acc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 2,849
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603309

Financial Performance

In 2025, Well Lead Medical's revenue was 1.63 billion, an increase of 8.07% compared to the previous year's 1.51 billion. Earnings were 76.33 million, a decrease of -65.21%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 28, 2026

Data Sources Report a data error